AU3011497A - Novel human growth factors - Google Patents

Novel human growth factors

Info

Publication number
AU3011497A
AU3011497A AU30114/97A AU3011497A AU3011497A AU 3011497 A AU3011497 A AU 3011497A AU 30114/97 A AU30114/97 A AU 30114/97A AU 3011497 A AU3011497 A AU 3011497A AU 3011497 A AU3011497 A AU 3011497A
Authority
AU
Australia
Prior art keywords
growth factors
human growth
novel human
novel
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30114/97A
Other languages
English (en)
Inventor
Patrick J. Dillon
Reinhard Ebner
Gregory A. Endress
Guo-Liang Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3011497A publication Critical patent/AU3011497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU30114/97A 1996-08-23 1997-09-11 Novel human growth factors Abandoned AU3011497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9613766 1996-08-23
WOUS9613766 1996-08-23
PCT/US1997/014139 WO1998007749A1 (fr) 1996-08-23 1997-08-22 Nouveaux facteurs de croissance humains

Publications (1)

Publication Number Publication Date
AU3011497A true AU3011497A (en) 1998-03-06

Family

ID=22255670

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30114/97A Abandoned AU3011497A (en) 1996-08-23 1997-09-11 Novel human growth factors

Country Status (4)

Country Link
EP (1) EP0929575A4 (fr)
JP (1) JP2002508652A (fr)
AU (1) AU3011497A (fr)
WO (1) WO1998007749A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1003779A1 (fr) * 1997-07-07 2000-05-31 Abbott Laboratories Reactifs et methodes utiles pour detecter des pathologies mammaires
US20040141974A1 (en) * 2000-02-25 2004-07-22 Boyd Robert Simon Diagnostic and therapeutic methods
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
AU2001233929C1 (en) * 2000-02-25 2006-03-02 Ucb Pharma S.A. Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer
AU2005218046B2 (en) * 2000-02-25 2008-07-03 Ucb Pharma S.A. Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer
WO2001084156A2 (fr) * 2000-04-28 2001-11-08 Millennium Pharmaceuticals, Inc. Compositions et techniques de definition, d'evaluation, de prevention et de therapie des cancers chez l'homme
EP1666492A1 (fr) * 2000-06-02 2006-06-07 Genentech, Inc. Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
RU2166957C1 (ru) * 2000-10-09 2001-05-20 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Тетрапептид, стимулирующий функциональную активность гепатоцитов, фармакологическое средство на его основе и способ его применения
GB0222787D0 (en) * 2002-10-02 2002-11-06 Univ Liverpool Metastasis inducing compounds
JP2004298112A (ja) * 2003-03-31 2004-10-28 Japan Science & Technology Agency ヒト固形癌抗原ペプチドとこれをコードするポリヌクレオチド、並びにそれらの利用
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
ES2299281B1 (es) * 2003-10-22 2009-04-16 Progenika Biopharma, S.A. Metodos para el diagnostico in vitro y pronostico in vitro del cancer de pancreas, y para el desarrollo de farmacos contra el cancer de pancreas.
JP2007520217A (ja) * 2004-01-27 2007-07-26 コンピュゲン ユーエスエイ，インク． 新規ヌクレオチドおよびアミノ酸配列、ならびにそれを用いた乳癌診断のためのアッセイおよび使用方法
WO2008026009A1 (fr) * 2006-08-29 2008-03-06 Oxford Genome Sciences (Uk) Ltd Protéine
WO2008104803A2 (fr) * 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Protéines
EP2575821B1 (fr) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Inhibiteurs de recyclage d'acide biliaire et satiogènes pour traitement du diabète, de l'obésité et d'états inflammatoires gastro-intestinaux
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
CA2852957C (fr) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Inhibiteurs du recyclage de l'acide biliaire pour traitement de l'hypercholemie et de la maladie cholestatique hepatique
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011217A2 (fr) * 1996-09-13 1998-03-19 Sagami Chemical Research Center Proteines humaines comportant des sequences de signaux secretoires et adn codant ces proteines
AU6762298A (en) * 1997-03-19 1998-10-12 Zymogenetics Inc. Secreted polypeptides with homology to xenopus cement gland proteins
DK1000146T3 (da) * 1997-08-01 2007-01-08 Serono Genetics Inst Sa 5' EST'er for non-vævsspecifikke secernerede proteiner

Also Published As

Publication number Publication date
EP0929575A4 (fr) 2004-09-08
WO1998007749A1 (fr) 1998-02-26
EP0929575A1 (fr) 1999-07-21
JP2002508652A (ja) 2002-03-19

Similar Documents

Publication Publication Date Title
EP0784967A3 (fr) Implant vertébral
AU4886297A (en) Artificial cornea
EP0797962A3 (fr) Implant plat
AU2226297A (en) Surgical model
AU2207797A (en) Human bikunin
AU1868595A (en) Human growth hormone
AU5407598A (en) Bone implant
AU5721798A (en) Human mage-like protein
AU3728197A (en) Human telomerase
AU3198297A (en) Biocompatible glue
AU1251797A (en) Novel heteroaryl-oxazolidinones
AU3011497A (en) Novel human growth factors
AU1566897A (en) Pruning implement
AU3921993A (en) Novel antler-derived bone growth factors
AU4480697A (en) Human nm23-like protein
AU5390396A (en) Extracellular/epidermal growth factor hcaba58x
AU2375495A (en) Prosthesis
AU2653095A (en) Fibroblast growth factor-14
AU3207195A (en) Growth stimulating factors
AU5471098A (en) Bone stimulating factor
AU1401495A (en) Human vascular ibp-like growth factor
AU4744997A (en) Novel human phospholemman-like protein
AU5723996A (en) Human rad
AU3873697A (en) Novel aryl-pyridazines
AU5487598A (en) Breast implant